ER study sheds light on hidden xylazine in opioid overdoses

NCT ID NCT06949605

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study measured the amount of xylazine—a dangerous animal sedative often mixed with opioids—in the blood and urine of 75 emergency room patients who had a non-fatal opioid overdose. The goal was to see how common xylazine is and how well test strips can detect it. The findings could help emergency doctors better identify and respond to this growing threat.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors quickly detect xylazine in opioid overdoses and guide better emergency treatment.

What could go wrong

This was a small, observational study that only measured levels—it did not test any treatment or prove that detection improves outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute opioid poisoning Opiate Overdose substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Icahn School of Medicine

    New York, New York, 10029, United States

  • NYC Health + Hospitals/Elmhurst

    Elmhurst, New York, 11373, United States